This analysis showed that despite the overall upregulation of the HOX genes in FLT3/ITD+ AML patients, HOX gene expression in FLT3/ITD+ PML-RARa+ patients was significantly lower compared to the FLT3/ITD+ patients without this fusion protein. Here, FLT3 is linked to acute myeloid leukemia.